Effect of treatment with methotrexate and coal tar on adipokine levels and indices of insulin resistance and sensitivity in patients with psoriasis vulgaris

Journal of the European Academy of Dermatology and Venereology

Volumn 29, Issue 1, 2015, Pages 69-76

  Rajappa, M ^a   Rathika, S ^a   Munisamy, M ^a   Chandrashekar, L ^a   Thappa, D M ^a  

^a JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; COAL TAR; INSULIN; INTERLEUKIN 6; LEPTIN; METHOTREXATE; RESISTIN; IMMUNOSUPPRESSIVE AGENT; KERATOLYTIC AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DOSE ESCALATION; FEMALE; FOLLOW UP; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; PSORIASIS AREA AND SEVERITY INDEX; PSORIASIS VULGARIS; PSORIATIC ARTHRITIS; SYSTEMIC THERAPY; TOPICAL TREATMENT; TREATMENT OUTCOME; TREATMENT RESPONSE; ADOLESCENT; AGED; BLOOD; CASE CONTROL STUDY; MIDDLE AGED; PROSPECTIVE STUDY; PSORIASIS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

ADIPONECTIN; ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; COAL TAR; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INSULIN RESISTANCE; INTERLEUKIN-6; KERATOLYTIC AGENTS; LEPTIN; MALE; METHOTREXATE; MIDDLE AGED; PROSPECTIVE STUDIES; PSORIASIS; RESISTIN; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84919841791     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/jdv.12451     Document Type: Article

References (28)

1. Davidovici BB, Sattar N, Prinz J, et al,. Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions. J Invest Dermatol 2010; 130: 1785-1796.
2. Shipman AR, Millington GW,. Obesity and the skin. Br J Dermatol 2011; 165: 743-750.
3. Gerdes S, Osadtschy S, Rostami-Yazdi M, Buhles N, Weichenthal M, Mrowietz U,. Leptin, adiponectin, visfatin and retinol-binding protein-4-mediators of comorbidities in patients with psoriasis? Exp Dermatol 2012; 21: 43-47.
4. Maury E, Brichard SM,. Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol Cell Endocrinol 2010; 314: 1-16.
5. Boehncke W, Boehncke S, Tobin AM, Kirby B,. The 'psoriatic march': a concept of how severe psoriasis may drive cardiovascular comorbidity. Exp Dermatol 2011; 20: 303-307.
6. Sharma A, Satyam A, Sharma JB,. Leptin, IL-10 and inflammatory markers (TNF-α, IL-6 and IL-8) in pre-eclamptic, normotensive pregnant and healthy non-pregnant women. Am J Reprod Immunol 2007; 58: 21-30.
7. Nakajima H, Nakajima M, Tarutani M, Morishige R, Sano S,. Kinetics of circulating Th17 cytokines and adipokines in psoriasis patients. Arch Dermatol Res 2011; 303: 451-455.
8. Griffiths CE, Christophers E, Barker JN, et al,. A classification of psoriasis vulgaris according to phenotype. Br J Dermatol 2007; 156: 258-262.
9. Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H, CASPAR Study Group. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006; 54: 2665-2673.
10. Langley RG,. Evaluating psoriasis with Psoriasis Area and Severity Index, Psoriasis Global Assessment, and Lattice System Physician's Global Assessment. J Am Acad Dermatol 2004; 51: 563-569.
11. Oda N, Imamura S, Fujita T, et al,. The ratio of leptin to adiponectin can be used as an index of insulin resistance. Metabolism 2008; 57: 268-273.
12. Ucak S, Ekmekci TR, Basat O, Koslu A, Altuntas Y,. Comparison of various insulin sensitivity indices in psoriatic patients and their relationship with type of psoriasis. J Eur Acad Dermatol Venereol 2006; 20: 517-522.
13. Setia S, Sridhar MG, Bhat V, Chaturvedula L, Vinayagamoorti R, John M,. Insulin sensitivity and insulin secretion at birth in intrauterine growth retarded infants. Pathology 2006; 38: 236-238.
14. Gerdes S, Rostami-Yazdi M, Mrowietz U,. Adipokines and psoriasis. Exp Dermatol 2011; 20: 81-87.
15. Bastard JP, Maachi M, Lagathu C, et al,. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 2006; 17: 4-12.
16. Groeneveld MP, Huang-Doran I, Semple RK,. Adiponectin and leptin in human severe insulin resistance-diagnostic utility and biological insights. Biochimie 2012; 94: 2172-2179.
17. Karadag AS, Yavuz B, Ertugrul DT, et al,. Is psoriasis a pre-atherosclerotic disease? Increased insulin resistance and impaired endothelial function in patients with psoriasis. Int J Dermatol 2010; 49: 642-646.
18. Boehncke S, Thaci D, Beschmann H, et al,. Psoriasis patients show signs of insulin resistance. Br J Dermatol 2007; 157: 1249-1251.
19. Coimbra S, Oliveira H, Reis F, et al,. Circulating adipokine levels in Portuguese patients with psoriasis vulgaris according to body mass index, severity and therapy. J Eur Acad Dermatol Venereol 2010; 24: 1386-1394.
20. Kawashima K, Torii K, Furuhashi T, et al,. Phototherapy reduces serum resistin levels in psoriasis patients. Photodermatol Photoimmunol Photomed 2011; 27: 152-155.
21. Takahashi H, Tsuji H, Ishida-Yamamoto A, Iizuka H,. Serum level of adiponectin increases and those of leptin and resistin decrease following the treatment of psoriasis. J Dermatol. 2013; 40: 475-476.
22. Boehncke S, Salgo R, Garbaraviciene J, et al,. Effective continuous systemic therapy of severe plaque-type psoriasis is accompanied by amelioration of biomarkers of cardiovascular risk: Results of a prospective longitudinal observational study. J Eur Acad Dermatol Venereol 2011; 25: 1187-1193.
23. Johnston A, Arnadottir S, Gudjonsson JE, et al,. Obesity in psoriasis: leptin and resistin as mediators of cutaneous inflammation. Br J Dermatol 2008; 159: 342-350.
24. Ozdemir M, Yüksel M, Gökbel H, Okudan N, Mevlitoʇlu I,. Serum leptin, adiponectin, resistin and ghrelin levels in psoriatic patients treated with cyclosporin. J Dermatol 2012; 39: 443-448.
25. Corbetta S, Angioni R, Cattaneo A, Beck-Peccoz P, Spada A,. Effects of retinoid therapy on insulin sensitivity, lipid profile and circulating adipocytokines. Eur J Endocrinol 2006; 154: 83-86.
26. Karadag AS, Ertugrul DT, Kalkan G, et al,. The effect of acitretin treatment on insulin resistance, retinol-binding protein-4, leptin, and adiponectin in psoriasis vulgaris: anoncontrolled study. Dermatology 2013; 227: 103-108. doi: 10.1159/000351769.
27. El-Barbary AM, Hussein MS, Rageh EM, Hamouda HE, Wagih AA, Ismail RG,. Effect of atorvastatin on inflammation and modification of vascular risk factors in rheumatoid arthritis. J Rheumatol 2011; 38: 229-235.
28. Prodanovich S, Ma F, Taylor JR, Pezon C, Fasihi T, Kirsner RS,. Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis. J Am Acad Dermatol 2005; 52: 262-267.